Living with AMD treatment: Patient experiences of being treated with Ranibizumab (Lucentis) intravitreal injections

Thetford, Clare orcid iconORCID: 0000-0003-2188-3052, Hodge, S, Harding, S, Taylor, S and Knox, P (2013) Living with AMD treatment: Patient experiences of being treated with Ranibizumab (Lucentis) intravitreal injections. British Journal of Visual Impairment, 31 (2). ISSN 0264-6196

[thumbnail of Version of Record]
Preview
PDF (Version of Record) - Published Version
Available under License Creative Commons Attribution Non-commercial.

414kB

Official URL: http://dx.doi.org/10.1177/0264619613481778

Abstract

This study reports the results of a qualitative study of patient experiences of receiving treatment for wet age-related macular degeneration with ranibizumab (Lucentis)(R). Treatment involved monthly hospital visits for assessment and, where required, an intravitreal Lucentis injection. Qualitative narrative interviews were conducted with 22 patients, 18 of whom received treatment and were interviewed at two points during their treatment journey. Interviews allowed participants to reflect on their experiences of being assessed for and receiving this treatment. Overall, treated participants reported that while they had been apprehensive about treatment, the actual experience of it was far less unpleasant than they had expected. However, the data also revealed a number of issues surrounding the provision of information about treatment, as well as service delivery issues, which had considerable impact upon their experience.


Repository Staff Only: item control page